Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary
2023-05-05 15:00
P&G Health commemorates Neuropathy Awareness Week 2023 with an effort to help people 'Put Life Back in Their Hands'
2023-05-05 11:30
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
2023-05-05 08:00
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery
2023-05-05 08:00
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor
2023-05-05 01:00
SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
2023-05-05 00:52
ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"
2023-05-04 21:00
Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health
2023-05-04 16:00
European Wellness Joint Research with Heidelberg University in Journal Publication
2023-05-04 13:39
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
2023-05-03 22:43
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial
2023-05-03 21:00
LenioBio GmbH Announces New CEO
2023-05-03 20:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting
2023-05-03 12:00
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea
2023-05-03 10:00
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
2023-05-03 08:00
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
2023-05-03 00:07
Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology
2023-05-02 12:01
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
2023-05-01 18:30
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
2023-05-01 08:58
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products
2023-04-29 23:20
1
110
111
112
113
114
453